GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Chenguang Biotech Group Co Ltd (SZSE:300138) » Definitions » Interest Expense

Chenguang Biotech Group Co (SZSE:300138) Interest Expense : ¥-117 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Chenguang Biotech Group Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Chenguang Biotech Group Co's interest expense for the three months ended in Mar. 2025 was ¥ -34 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-117 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Chenguang Biotech Group Co's Operating Income for the three months ended in Mar. 2025 was ¥ 144 Mil. Chenguang Biotech Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥ -34 Mil. Chenguang Biotech Group Co's Interest Coverage for the quarter that ended in Mar. 2025 was 4.24. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Chenguang Biotech Group Co Interest Expense Historical Data

The historical data trend for Chenguang Biotech Group Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chenguang Biotech Group Co Interest Expense Chart

Chenguang Biotech Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -78.07 -53.15 -67.21 -83.51 -114.42

Chenguang Biotech Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -31.76 -33.39 -18.69 -30.59 -33.86

Chenguang Biotech Group Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-117 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chenguang Biotech Group Co  (SZSE:300138) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chenguang Biotech Group Co's Interest Expense for the three months ended in Mar. 2025 was ¥-34 Mil. Its Operating Income for the three months ended in Mar. 2025 was ¥144 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ¥1,072 Mil.

Chenguang Biotech Group Co's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2025 )/Interest Expense (Q: Mar. 2025 )
=-1*143.636/-33.855
=4.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Chenguang Biotech Group Co Ltd interest coverage is 2.82, which is low.


Chenguang Biotech Group Co Business Description

Traded in Other Exchanges
N/A
Address
Number 1 Chenguang Road, Hebei Province, Quzhou, CHN, 057250
Chenguang Biotech Group Co Ltd is engaged in the processing of agricultural products and herb extracts in China. Its products include natural colors, including paprika oleoresin, marigold oleoresin, curcumin, red rice red, red cabbage, and red beet; and natural spice extracts and essential oils, such as capsicum oleoresin, zanthoxylum oil and oleoresin, black pepper oil and oleoresin, ginger oil and oleoresin, turmeric oil, star anise oil and oleoresin, cumin oil and oleoresin, garlic oil and oleoresin, and common fennel oil and oleoresin.
Executives
Li Feng Fei Executives
Zhou Jing Directors, Directors, and Executives
Li Yue Zhai Director
Lian Yun He Executives
Chen Yun Xia Executives
Zhao Tao Supervisors
Yuan Xin Ying Supervisors
Liu Zhang Lin Independent director
Lu Qing Guo Directors, executives
Zhou Fang Sheng Independent director
Wang Shu Hong Independent director
Liu Ying Shan Director
Han Wen Jie Executives
Liu Dong Ming Supervisors
Yang Wen Fang Supervisors

Chenguang Biotech Group Co Headlines

No Headlines